|
JP2021001142A
|
|
Hydroxytyrosol-containing soft capsule agent
|
|
JP2020055766A
|
|
Soft capsule agent containing dutasteride
|
|
JP2018146313A
|
|
Dissolution test method for soft capsules containing nalfurafine hydrochloride
|
|
JP2018065775A
|
|
Composition for capsule filling containing nalfurafine hydrochloride, soft capsule agent and method for producing the same
|
|
JP2014227381A
|
|
Loxoprofen sodium-containing oral capsule
|
|
JP2014014785A
|
|
Apparatus and method for producing seamless capsule
|
|
JP2014009211A
|
|
Sol pharmaceutical composition containing itraconazole
|
|
JP2012180287A
|
|
Composition for capsule filling of candesartan cilexetil
|
|
JP2012111712A
|
|
Composition for oil vitamin c oral administration
|
|
JP2012001487A
|
|
Tacrolimus-containing capsule
|
|
JP2011219371A
|
|
Capsule containing ketotifen fumarate
|
|
JP2011111418A
|
|
Viral infection-preventing preparation suitable for intra-oral cavity local administration
|
|
JP2011084521A
|
|
Azelastine hydrochloride-containing capsule preparation
|
|
JP2010077095A
|
|
Vitamin e containing soft capsule
|
|
JP2009007262A
|
|
Bisphosphonate formulation
|
|
JP2008150298A
|
|
Diphenhydramine-containing medicine composition having improved solubility
|
|
JP2008137933A
|
|
Vaccine preparation for oral administration
|
|
JP2007020425A
|
|
Nutritive functional material derived from fish of family zoarcidae
|
|
JP2007020424A
|
|
Method for producing nutritive functional material derived from fish of family zoarcidae
|
|
JP2006333790A
|
|
Food for improving pain at time of menstruation
|
